Ranxin Shi

1.6k total citations · 1 hit paper
11 papers, 1.4k citations indexed

About

Ranxin Shi is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Ranxin Shi has authored 11 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 5 papers in Cancer Research and 4 papers in Oncology. Recurrent topics in Ranxin Shi's work include Cell death mechanisms and regulation (5 papers), NF-κB Signaling Pathways (5 papers) and Cancer-related Molecular Pathways (3 papers). Ranxin Shi is often cited by papers focused on Cell death mechanisms and regulation (5 papers), NF-κB Signaling Pathways (5 papers) and Cancer-related Molecular Pathways (3 papers). Ranxin Shi collaborates with scholars based in United States, Singapore and China. Ranxin Shi's co-authors include Han‐Ming Shen, Yong Lin, Xia Wang, Choon Nam Ong, John C. Reed, Xinqiang Zhu, Bin Zhao, Lu Jia, Qing Huang and Irina V. Lebedeva and has published in prestigious journals such as Molecular Cell, PLoS ONE and Cancer Research.

In The Last Decade

Ranxin Shi

11 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Luteolin, a Flavonoid with Potential for Cancer Prevention and Therapy

2008 931 citations Yong Lin, Ranxin Shi et al. Current Cancer Drug Targets profile →

Peers

Countries citing papers authored by Ranxin Shi

Since Specialization

Citations

This map shows the geographic impact of Ranxin Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ranxin Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ranxin Shi more than expected).

Fields of papers citing papers by Ranxin Shi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ranxin Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ranxin Shi. The network helps show where Ranxin Shi may publish in the future.

Co-authorship network of co-authors of Ranxin Shi

This figure shows the co-authorship network connecting the top 25 collaborators of Ranxin Shi. A scholar is included among the top collaborators of Ranxin Shi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ranxin Shi. Ranxin Shi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

#	Work	Indexed citations
1	PCTAIRE1-Knockdown Sensitizes Cancer Cells to TNF Family Cytokines 2015 ·PLoS ONE ·Teruki Yanagi, Ranxin Shi, Pedro Aza‐Blanc, John C. Reed, Shu‐ichi Matsuzawa	19
2	ARTS and Siah Collaborate in a Pathway for XIAP Degradation 2010 ·Molecular Cell ·Jason B. Garrison, Ricardo G. Correa, Motti Gerlic, Kenneth W. Yip, Andreas Krieg, (unknown), Ranxin Shi, Kate Welsh, Srinivas Duggineni, Ziwei Huang, Keqin Ren, Chunying Du, John C. Reed	50
3	Selective benzimidazole inhibitors of the antigen receptor-mediated NF-κB activation pathway 2010 ·Bioorganic & Medicinal Chemistry ·Karl J. Okolotowicz, Ranxin Shi, Xueying Zheng, Mary MacDonald, John C. Reed, John R. Cashman	11
4	Chemical Biology Strategy Reveals Pathway-Selective Inhibitor of NF-κB Activation Induced by Protein Kinase C 2010 ·ACS Chemical Biology ·Ranxin Shi, Daniel Ré, Eric Dudl, Michael Cuddy, Karl J. Okolotowicz, Russell Dahl, Ying Su, (unknown), Shinichi Kitada, Satyamaheshwar Peddibhotla, Gregory P. Roth, Layton H. Smith, Thomas J. Kipps, Nicholas D. P. Cosford, John R. Cashman, John C. Reed	14
5	Inhibition of Protein Kinase C-Driven Nuclear Factor-κB Activation: Synthesis, Structure−Activity Relationship, and Pharmacological Profiling of Pathway Specific Benzimidazole Probe Molecules 2010 ·Journal of Medicinal Chemistry ·Satyamaheshwar Peddibhotla, Ranxin Shi, (unknown), Layton H. Smith, Arianna Mangravita-Novo, Michael Vicchiarelli, Ying Su, Karl J. Okolotowicz, John R. Cashman, John C. Reed, Gregory P. Roth	16
6	Apoptotic Activity and Mechanism of 2-Cyano-3,12-Dioxoolean-1,9-Dien-28-Oic-Acid and Related Synthetic Triterpenoids in Prostate Cancer 2008 ·Cancer Research ·Marc L. Hyer, Ranxin Shi, Maryla Krajewska, Colin J. Meyer, Irina V. Lebedeva, Paul B. Fisher, John C. Reed	52
7	Luteolin, a Flavonoid with Potential for Cancer Prevention and Therapy breakdown → 2008 ·Current Cancer Drug Targets ·Yong Lin, Ranxin Shi, Xia Wang, Han‐Ming Shen	931
8	Luteolin sensitizes the anticancer effect of cisplatin via c-Jun NH2-terminal kinase–mediated p53 phosphorylation and stabilization 2007 ·Molecular Cancer Therapeutics ·Ranxin Shi, Qing Huang, Xinqiang Zhu, (unknown), Bin Zhao, Lu Jia, Choon Nam Ong, Han‐Ming Shen	80
9	Protein Kinase C Inhibition and X-Linked Inhibitor of Apoptosis Protein Degradation Contribute to the Sensitization Effect of Luteolin on Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand–Induced Apoptosis in Cancer Cells 2005 ·Cancer Research ·Ranxin Shi, Choon Nam Ong, Han‐Ming Shen	89
10	Luteolin sensitizes tumor necrosis factor-α-induced apoptosis in human tumor cells 2004 ·Oncogene ·Ranxin Shi, Choon Nam Ong, Han‐Ming Shen	89
11	Antitumor activity of degraded Chondrus ocellatus polysaccharide 2000 ·Haiyang yu huzhao ·Ranxin Shi, Zuhong Xu, Zhien Li	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact